Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, has announced that Manuel Llobet, Chief Executive Officer, Nick Wykeman, Chief Financial Officer, and Alan Bullimore, Head of Business Innovation of Allergy Therapeutics, will present at the Virtual H.C. Wainwright Global Investor Conference taking place from September 13-15, 2021. The presentation will be made available on-demand for participants from Monday, 13 September 2021.
A copy of the presentation will be made available under the ‘Investors’ section on Allergy Therapeutics’ website at: www.allergytherapeutics.com/investors/results-reports-and-presentations/